OnKure Therapeutics, Inc.
OKUR
$3.99
$0.092.31%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 14.98% | 11.63% | 41.73% | 110.38% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.87% | 2.46% | 18.96% | 48.32% | -- |
| Operating Income | 0.87% | -2.46% | -18.96% | -48.32% | -- |
| Income Before Tax | 2.67% | 0.53% | -12.99% | -42.00% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 2.67% | 0.53% | -12.99% | -42.00% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.67% | 0.53% | -12.99% | -42.00% | -- |
| EBIT | 0.87% | -2.46% | -18.96% | -48.32% | -- |
| EBITDA | 0.78% | -2.53% | -19.15% | -48.80% | -- |
| EPS Basic | 91.31% | 94.84% | 96.11% | 95.75% | -- |
| Normalized Basic EPS | 91.30% | 94.71% | 96.03% | 95.74% | -- |
| EPS Diluted | 91.31% | 94.84% | 96.11% | 95.75% | -- |
| Normalized Diluted EPS | 91.30% | 94.71% | 96.03% | 95.74% | -- |
| Average Basic Shares Outstanding | 126.54% | 102.43% | 294.03% | 272.70% | -- |
| Average Diluted Shares Outstanding | 126.54% | 102.43% | 294.03% | 272.70% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |